[Other] Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): a randomised, open-label, multicentre, phase 3 trial

Marilena Post time 2024-4-23 17:42:23 | Show all posts |Read mode
Reward10points




Best Answer

Please adopt

View Full Content

Reply

Use magic Donate Report

All Reply1 Show all posts
spinon Post time 2024-4-23 17:42:24 | Show all posts

This post has been completed

Completed attachments will be deleted within 24 hours.
Reply

Use magic Donate Report


Junior Member
  • post

  • reply

  • points

    190

Latest Reply



Return to the list